Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Nav

General Info

Geography

United States of America (USA)

Time period covered

01/2011 - 12/2016

Data type

Scientific literature

Keywords

Ischemic heart disease

Citation

Authors

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM, REDUCE-IT Investigators

Journal

N Engl J Med

Volume

380

Issue

Pages

11-22

Publication year

2019

Suggested citation

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM, REDUCE-IT Investigators. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019; 380(1): 11-22.

DOI

10.1056/NEJMoa1812792

PMID

30415628

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Nav